3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Stomach Neoplasms
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Fanconi Anemia
1
Erythroplasia
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
epigallocatechin gallate
1
aldesleukin
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Transdermal Patch
1
Restraint, Physical
1
Respiratory Function Tests
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nicotine Replacement Therapy
1
Molecular Diagnostic Techniques
1
Meperidine
1
Magnetic Resonance Imaging
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Human Papillomavirus DNA Tests
1
Granisetron
1
Focus Groups
1
Electrocardiography
1
Droperidol
1
Doxylamine
1
Diphenoxylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Molecular Diagnostic Techniques
×
90 days
×
Clear all
NCT02328872
2026-04-17
Compass
VCS Foundation
Phase NA
Active not recruiting
76,181 enrolled